Quick Answer
Solid Biosciences Inc. reported Common Stock Shares Outstanding of 78.97 million shares for the year ending 2025.
- Solid Biosciences Inc. showed an increase of +95.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Solid Biosciences Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: 35.48 million shares | Q2 2018: 35.44 million shares | Q3 2018: 35.43 million shares | Q1 2019: 35.41 million shares | Q2 2019: 35.40 million shares | Q3 2019: 46.00 million shares | Q1 2020: 46.07 million shares | Q2 2020: 45.99 million shares | Q3 2020: 46.18 million shares | Q1 2021: 110.29 million shares | Q2 2021: 110.30 million shares | Q3 2021: 110.30 million shares | Q1 2022: 112.78 million shares | Q2 2022: 112.96 million shares | Q3 2022: 7.53 million shares | Q1 2023: 19.57 million shares | Q2 2023: 20.04 million shares | Q3 2023: 20.06 million shares | Q1 2024: 37.83 million shares | Q2 2024: 38.55 million shares | Q3 2024: 38.93 million shares | Q1 2025: 77.49 million shares | Q2 2025: 77.60 million shares | Q3 2025: 77.88 million shares.
- Historical annual values: Fiscal year 2025: 78.97 million shares | Fiscal year 2024: 40.47 million shares | Fiscal year 2023: 20.39 million shares | Fiscal year 2022: 19.56 million shares | Fiscal year 2021: 7.36 million shares | Fiscal year 2020: 84.89 million shares | Fiscal year 2019: 45.99 million shares | Fiscal year 2018: 35.43 million shares | Fiscal year 2017: 0 shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: